Figure S7 from The Impact of the Tumor Microenvironment on the Effect of IL-1β Blockade in NSCLC: Biomarker Analyses from CANOPY-1 and CANOPY-N Trials Article Swipe
Related Concepts
Canopy
Blockade
Biomarker
Oncology
Internal medicine
Medicine
Geography
Biology
Botany
Genetics
Receptor
Benjamin Solomon
,
Daniel S.W. Tan
,
Gilberto de Castro
,
Manuel Cobo
,
Marina Chiara Garassino
,
Jun Zhang
,
Bruce E. Johnson
,
Jay M. Lee
,
Pilar Garrido
,
A. R. BUTLER
,
Marc R. Pelletier
,
Alexander Savchenko
,
Lexiang Ji
,
Jan C. Brase
,
Rafael Caparica
,
David Demanse
,
Jincheng Wu
,
Claudia Bossen
,
Tony Mok
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1158/2767-9764.29051519
· OA: W4410344458
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1158/2767-9764.29051519
· OA: W4410344458
<p>A, CD8 central tumor levels by PD-L1 subgroups and B, summary of patient characteristics at baseline by PD-L1 subgroup for CANOPY-1.</p>
Related Topics
Finding more related topics…